Keiko Suzaki

Safety and efficacy of faldaprevir in combination with pegylated interferon α‐2b and ribavirin in Japanese patients with genotype‐1 chronic hepatitis C virus infection

M. Omata, A. Taniguchi, S. Nishiguchi, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the SustaIMM phase 2/3 trial

M. Ohtsuki, J. Valdes, H. Fujita, 2019, The Journal of dermatology.

Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes

D. Yabe, Y. Seino, T. Meinicke, 2021, BMJ Open.

Empagliflozin as add‐on to linagliptin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52‐week, randomized, placebo‐controlled trial

R. Kawamori, M. Haneda, J. George, 2018, Diabetes, obesity & metabolism.